Graft-versus-host driven graft-versus-leukemia effect of minor histocompatibility antigen HA-1 in chronic myeloid leukemia patients.
T
T
Mutis
R
R
Brand
D
D
Gallardo
A
A
van Biezen
D
D
Niederwieser
E
E
Goulmy
D000293:Adolescent; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D005260:Female; D006086:Graft vs Host Disease; D020544:Graft vs Leukemia Effect; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D015778:Minor Histocompatibility Antigens / Q000378:metabolism*; D009364:Neoplasm Recurrence, Local / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D009842:Oligopeptides / Q000378:metabolism*; D033581:Stem Cell Transplantation; D015996:Survival Rate; D016896:Treatment Outcome; D055815:Young Adult
C110615:HA-1 antigen; D015778:Minor Histocompatibility Antigens; D009842:Oligopeptides